Autopsy report · NCT02744833
Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
Cause of deathFunding or business
“The trial was funded in part by a grant; the trial closed when the grant ended.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 4 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- GlycoMimetics Incorporated
- Sponsor type
- Industry
- Conditions
- Deep Venous Thrombosis
- Interventions
- GMI-1271; Enoxaparin Sodium (Lovenox®)
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
“The PI left the Institution and sponsor decided to close the trial.” - Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
“The trial closed early due to slow accrual.” - Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
“The trial is closing due to findings from a related study, prompting the sponsor to discontinue development and end this study.” - Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
“it was decided that due to lack of accrual on the trial, and low potential for accruing over the near future, the trial will be shut down.” - A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
“Trial was cancelled by Sponsor”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.